Exclusive: Ziopharm Oncology CEO Wants To Disrupt The CAR-T Supply Chain

Ziopharm Oncology Inc. (NASDAQ: ZIOP) has two goals. One is to disrupt the narrative around recurrent glioblastomas. The other is to ...